<p>The present invention relates to methods and compositions for the treatment or prevention of type 2 diabetes by administering an effective amount of a melatonin receptor agonist to a human subject in need of such treatment or prevention.</p>
申请公布号
WO2011112167(A1)
申请公布日期
2011.09.15
申请号
WO2010US00783
申请日期
2010.03.15
申请人
RESET THERAPEUTICS, INC.;TAKAHASHI, JOSEPH, S.;KAY, STEVE, A.
